Literature DB >> 26392462

Stat1 Regulates Lupus-like Chronic Graft-versus-Host Disease Severity via Interactions with Stat3.

Wen-Hai Shao1, Ana M Gamero2, Yuxuan Zhen3, Monica J Lobue3, Stephen O Priest3, Hazem J Albandar3, Philip L Cohen3.   

Abstract

Systemic lupus erythematosus (SLE) is a complex multisystem autoimmune disease, characterized by a spectrum of autoantibodies that target multiple cellular components. Glomerulonephritis is a major cause of morbidity in patients with SLE. Little is known about the pathogenesis of SLE renal damage and compromised renal function. Activation of both Stat1 and Stat3 has been reported in lupus and lupus nephritis. The reciprocal activation of these two transcription factors may have a major impact on renal inflammation. To study the role of Stat1 in a lupus model, we induced lupus-like chronic graft-versus-host disease (cGVHD) in Stat1-knockout (KO) and wild-type (WT) mice by i.p. injection of class II-disparate bm12 splenocytes. WT recipients of these alloreactive cells developed anti-dsDNA autoantibodies starting at week 2 as expected, with a decline after week 4. In contrast, Stat1-KO hosts exhibited a prolonged and significant increase of anti-dsDNA autoantibody responses compared with WT mice (week 4 to week 8). Increased autoantibody titers were accompanied by increased proteinuria and mortality in the cGVHD host mice lacking Stat1. Further analysis revealed expression and activation of Stat3 in the glomeruli of Stat1-KO host mice but not WT mice with cGVHD. Glomerular Stat3 activity in the Stat1-KO mice was associated with increased IL-6 and IFN-γ secretion and macrophage infiltration. Interactions between Stat1 and Stat3 thus appear to be crucial in determining the severity of lupus-like disease in the cGVHD model.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26392462      PMCID: PMC4610853          DOI: 10.4049/jimmunol.1501353

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

Review 1.  The chronic graft-versus-host model of systemic autoimmunity.

Authors:  Robert Eisenberg
Journal:  Curr Dir Autoimmun       Date:  2003

Review 2.  Systemic lupus erythematosus.

Authors:  George C Tsokos
Journal:  N Engl J Med       Date:  2011-12-01       Impact factor: 91.245

3.  Phenotyping renal leukocyte subsets by four-color flow cytometry: characterization of chemokine receptor expression.

Authors:  Volker Vielhauer; Hans-Joachim Anders; Guillermo Pérez de Lema; Bruno Luckow; Detlef Schlöndorff; Matthias Mack
Journal:  Nephron Exp Nephrol       Date:  2003

4.  Delayed tyrosine phosphorylation and nuclear expression of STAT1 following antigen receptor stimulation of B lymphocytes.

Authors:  J G Karras; L Huo; Z Wang; D A Frank; J M Zimmet; T L Rothstein
Journal:  J Immunol       Date:  1996-09-15       Impact factor: 5.422

5.  Expression and activation of STAT3 in chronic proliferative immune complex glomerulonephritis and the effect of fosinopril.

Authors:  Wuxing Zhang; Xiangmei Chen; Suozhu Shi; Ribao Wei; Jianzhong Wang; Nobuaki Yamanaka; Quan Hong
Journal:  Nephrol Dial Transplant       Date:  2005-03-08       Impact factor: 5.992

6.  Alternative activation of STAT1 and STAT3 in response to interferon-gamma.

Authors:  Yulan Qing; George R Stark
Journal:  J Biol Chem       Date:  2004-07-27       Impact factor: 5.157

7.  Interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration.

Authors:  Congcong Zhang; Yulin Li; Yina Wu; Luya Wang; Xiaonan Wang; Jie Du
Journal:  J Biol Chem       Date:  2012-11-26       Impact factor: 5.157

Review 8.  IFNα Inducible Models of Murine SLE.

Authors:  Zheng Liu; Anne Davidson
Journal:  Front Immunol       Date:  2013-10-02       Impact factor: 7.561

Review 9.  Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical Aspects.

Authors:  Emanuele Cozzani; Massimo Drosera; Giulia Gasparini; Aurora Parodi
Journal:  Autoimmune Dis       Date:  2014-02-06

10.  Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease.

Authors:  Sarah E Flanagan; Emma Haapaniemi; Mark A Russell; Richard Caswell; Hana Lango Allen; Elisa De Franco; Timothy J McDonald; Hanna Rajala; Anita Ramelius; John Barton; Kaarina Heiskanen; Tarja Heiskanen-Kosma; Merja Kajosaari; Nuala P Murphy; Tatjana Milenkovic; Mikko Seppänen; Åke Lernmark; Satu Mustjoki; Timo Otonkoski; Juha Kere; Noel G Morgan; Sian Ellard; Andrew T Hattersley
Journal:  Nat Genet       Date:  2014-07-20       Impact factor: 38.330

View more
  7 in total

1.  Opposing Roles of Tyrosine Kinase Receptors Mer and Axl Determine Clinical Outcomes in Experimental Immune-Mediated Nephritis.

Authors:  Yuxuan Zhen; Stephen O Priest; Wen-Hai Shao
Journal:  J Immunol       Date:  2016-08-15       Impact factor: 5.422

2.  Anti-Double-Stranded DNA IgG Participates in Renal Fibrosis through Suppressing the Suppressor of Cytokine Signaling 1 Signals.

Authors:  Ping Wang; Jie Yang; Fang Tong; Zhaoyang Duan; Xingyin Liu; Linlin Xia; Ke Li; Yumin Xia
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

3.  Ezh2-mediated epigenetic modification is required for allogeneic T cell-induced lupus disease.

Authors:  Yuxuan Zhen; Roger D Smith; Fred D Finkelman; Wen-Hai Shao
Journal:  Arthritis Res Ther       Date:  2020-06-05       Impact factor: 5.156

Review 4.  An aberrant STAT pathway is central to COVID-19.

Authors:  Toshifumi Matsuyama; Shawn P Kubli; Steven K Yoshinaga; Klaus Pfeffer; Tak W Mak
Journal:  Cell Death Differ       Date:  2020-10-09       Impact factor: 15.828

5.  D-mannose ameliorates autoimmune phenotypes in mouse models of lupus.

Authors:  Haiting Wang; Xiangyu Teng; Georges Abboud; Wei Li; Shuang Ye; Laurence Morel
Journal:  BMC Immunol       Date:  2021-01-05       Impact factor: 3.615

Review 6.  COVID-19 and the potential of Janus family kinase (JAK) pathway inhibition: A novel treatment strategy.

Authors:  Mansoor Khaledi; Fatemeh Sameni; Sheida Yahyazade; Maedeh Radandish; Parviz Owlia; Nader Bagheri; Hamed Afkhami; Mohamad Mahjoor; Zahra Esmaelpour; Maryam Kohansal; Farzad Aghaei
Journal:  Front Med (Lausanne)       Date:  2022-08-30

7.  T-bet+CD11c+ B cells are critical for antichromatin immunoglobulin G production in the development of lupus.

Authors:  Ya Liu; Shiyu Zhou; Jie Qian; Yan Wang; Xiang Yu; Dai Dai; Min Dai; Lingling Wu; Zhuojun Liao; Zhixin Xue; Jiehua Wang; Goujun Hou; Jianyang Ma; John B Harley; Yuanjia Tang; Nan Shen
Journal:  Arthritis Res Ther       Date:  2017-10-05       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.